Bupropion News and Research

RSS

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

Scientists have found that a new anti-smoking drug may be more effective than drugs currently in use to help smokers kick the habit and it has the added advantage of promoting longer-lasting abstinence.

5 Jul 2006

Varenicline effective in helping smokers quit

The drug varenicline shows effectiveness in helping smokers quit and abstain from smoking when compared to placebo and the smoking cessation medication bupropion.

4 Jul 2006

New drug will treat those winter blues

The U.S. Food and Drug Administration (FDA) has given it's approval for a drug to treat a condition known as Seasonal Affective Disorder (SAD).

14 Jun 2006

FDA approves Wellbutrin X for treatment of seasonal depression

The Food and Drug Administration (FDA) has approved Wellbutrin XL for prevention of major depressive episodes in patients with a history of seasonal affective disorder (SAD).

13 Jun 2006

Varenicline could increase number who quit smoking

Smokers who try to quit using existing medications, such as nicotine patches or Zyban, are about twice as likely to succeed as those who don't use medication or are prescribed placebos during clinical trials.

3 May 2006

Depression treatment may require different drugs for different people

If a first antidepressant medication doesn't work, try a different one, UT Southwestern Medical Center researchers report.

27 Mar 2006

Psychiatric patients who smoke

An editorial in the January 2006 issue of the Psychiatric Bulletin reviews the evidence for the effectiveness of gene-based smoking cessation packages, and asks whether they are appropriate for psychiatric patients.

10 Jan 2006

Killer secondhand smoke campaign flares up in the UK

According to new research by the National Health Service (NHS), 60 per cent of smokers light up and smoke without asking for permission, despite the fact that most non-smokers mind if other people are smoking nearby.

6 Sep 2005

Genetic makeup may detemine likely success of quit smoking therapies

A study by researchers at the Transdisciplinary Tobacco Use Research Center (TTURC) of the University of Pennsylvania School of Medicine indicates that a smoker's genetic make-up may affect whether they quit or not while using either bupropion (Zyban) or nicotine replacement therapies (NRTs) such as the nicotine patch or nasal spray.

30 Aug 2005

Health insurance that pays the full cost of smoking-cessation treatments can increase quit rates

Health insurance that pays the full cost of smoking-cessation treatments can increase quit rates, compared to benefit plans that pick up only part of the tab or that offer no cessation benefits at all, according to a new review of studies.

22 Feb 2005

Few smokers make use of the help that is available

Antidepressant medicines, nicotine replacement products, and counseling can all help a smoker stick with that New Year's resolution to kick the habit. But a study by American Cancer Society researchers finds that few smokers make use of the help that is available.

17 Jan 2005

Quitting smoking can be made easier with long-term comprehensive drug and psychological interventions

People who want to quit smoking have an improved chance of success if they receive long-term comprehensive drug and psychological interventions, according to a new study by UCSF researchers.

4 Nov 2004

Long-term medication and counseling helps smokers quit

People who want to quit smoking have an improved chance of success if they receive long-term comprehensive drug and psychological interventions, according to a new study by UCSF researchers.

1 Nov 2004

Nicotine replacement therapy shown to help teenagers and women

In the first study, researchers at the Stanford University School of Medicine have found that the nicotine patch seems to work as well, at least initially, for teens as it does for adults. In addition, the patch, the top delivery form of NRT (followed by gum, an inhaler and a nasal spray) worked equally well with or without supplementation by an anti-depressant given to the teens.

21 Aug 2004

Smoking may be on the rise again

The statistics are alarming: About one in five high school seniors smoke cigarettes daily. Yet nearly half a million Americans die prematurely from tobacco-related disease and smoking is projected to in some way kill one third of all smokers.

15 Aug 2004

Newborns may be harmed when pregnant women take Selective Serotonin Re-uptake Inhibitors (SSRIs) and other anti-depressants during the third trimester of pregnancy

Health Canada is advising Canadians that newborns may be adversely affected when pregnant women take Selective Serotonin Re-uptake Inhibitors (SSRIs) and other newer anti-depressants during the third trimester of pregnancy.

9 Aug 2004

Canadians advised of stronger warnings for selective serotonin re-uptake inhibitors and other newer anti-depressants

Health Canada is advising Canadians that Selective Serotonin Re-uptake Inhibitors (SSRIs) and other newer anti-depressants, now carry stronger warnings. These new warnings indicate that patients of all ages taking these drugs may experience behavioural and/or emotional changes that may put them at increased risk of self-harm or harm to others.

11 Jun 2004

Vast majority of college smokers don't quit

Almost 90 percent of college students who were daily smokers and 50 percent of occasional smokers were still smoking four years later, according to a study conducted at the University of Wisconsin-Madison and just published in the current issue of Health Psychology.

14 Apr 2004